In a significant milestone, more than 100 children with cancer from across the East of England have had their tumours tested by whole genome sequencing (WGS) and interpreted by scientists in the NHS Genomic Medicine Service at Cambridge University Hospitals NHS Foundation Trust (CUH), to help improve their diagnosis and treatment.
Professor David Rowitch, Academic Lead at Cambridge Children’s Hospital, commented:
“We are using WGS to benefit the sickest children with rare genetic diseases and cancer.
“The findings are transforming the routine practice of paediatrics and we can do more to improve treatment. Thus we are building the new NHS Cambridge Children’s Hospital to be a world’s first facility, integrating both physical-mental healthcare and genomic research.”
To read the full article, visit East Genomics.nhs.uk